Results 71 to 80 of about 12,887 (114)

A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila [PDF]

, 2014
Development of effective malaria vaccines is hampered by the problem of producing correctly folded Plasmodium proteins for use as vaccine components.
A Huckriede, A Shevchenko, AF Egan, AF Egan, Alison M. Creasey, AP Turkewitz, AVS Hill, AW Stowers, B Sauer, BR Burgess, C Uthaipibull, CD Galamo, CF Ockenhouse, CG Adda, CHM Kocken, D Cassidy-Hanley, D Dodoo, D Gaur, D Hellenbroich, David R. Cavanagh, DB Smith, DC Gowda, DC Gowda, DE Arnot, DI Stanisic, DJ Conway, DK Moss, DP Mawili-Mboumba, DR Cavanagh, DR Cavanagh, DR Milich, DS Peterson, F Gharahdaghi, F Khan, G Jiang, GJM Cowan, Graeme J. M. Cowan, I Aldag, IA Quakyi, Ingo Aldag, J Gaertig, J Gaertig, JA Eisen, Janna Eleni-Muus, JC Pizarro, JJ Babon, JJ Gaertig, JS McBride, JS McBride, K Tanabe, Kay Samuel, LH Miller, M Parra, Marcus W. W. Hartmann, ME Victor, MJ Blackman, MJ Blackman, MJ Blackman, MJ Gardner, OS Lau, P Tompa, P Tompa, PA Burghaus, PD Crompton, Photini Sinnis, PR Sanders, PR Sanders, RR Garrity, SD Polley, T Kiy, T Weide, T Weide, UK Laemmli, Ulrike Bockau, V Chitarra, WA Keitel, WD Morgan, WD Morgan, Y Pollack, Y Shang   +79 more
core   +2 more sources

Bovine cytotoxic T cell clones which recognize lymphoblasts infected with two antigenically different stocks of the protozoan parasite Theileria parva

European Journal of Immunology, 1987
AbstractThe Muguga and Marikebuni stocks of Theileria parva differ on the basis of cross‐protection and in their schizont antigen profile determined with a panel of parasitespecific monoclonal antibodies. The phenotype and specificity of six cytotoxic T cell clones generated from an animal immunized against T. parva (Marikebuni) were investigated.
Morrison, W. Ivan, Goddeeris, M., Teale, A.J.   +2 more
openaire   +4 more sources

First detection of intestinal microsporidia in Northern Nigeria [PDF]

, 2005
Microsporidia are intracellular spore-forming protozoa that are increasingly being recognized as pathogens in humans. Faecal samples were taken from 2250 HIV/AIDS and 1050 HIV-negative patients from Kano and Makurdi in Northern Nigeria, and were ...
A B, Yako, D D, Duhlinska, G I, Anyanwu, I CJ, Omalu, P U, Inyama, V A, Pam   +5 more
core   +1 more source

Vaccines against toxoplasma gondii : challenges and opportunities [PDF]

, 2009
Development of vaccines against Toxoplasma gondii infection in humans is of high priority, given the high burden of disease in some areas of the world like South America, and the lack of effective drugs with few adverse effects.
Aliberti J, Angus CW, Aosai F, Aosai F, Awan KJ, Beghetto E, Bommireddy R, Bonenfant C, Boyle JP, Brinkmann V, Buxton D, Bülow R, Caetano BC, Conacher M, Cong H, Cong H, Constant SL, Couper KN, Craig W Roberts, Cui YL, Cuppari AF, Curtsinger JM, Curtsinger JM, Cutchins EC, Darcy F, Dautu G, Debard N, Debierre-Grockiego F, DeGregorio E, Denkers EY, Desolme B, Duquesne V, Echeverria PC, Elisabeth Förster-Waldl, Erik Jongert, Escajadillo A, Eskild Petersen, Fachado A, Fachado A, Flori P, Fox B, Frenkel JK, Garcia JL, Garcia JL, Gatkowska J, Gazzinelli R, Gazzinelli RT, Golkar M, Hakim FT, Igarashi M, Innes EA, Ishii K, Ishii KJ, Ismael AB, Ismael AB, Johnson LL, Jongert E, Jongert E, Jongert E, Kasper LH, Khan IA, Kijlstra A, Kodjikian L, Krahenbuhl JL, Kringel H, Letscher-Bru V, Letscher-Bru V, Leyva R, Lindsay DS, Liu Q, Lourenco EV, Lourenço EV, Martin V, McLeod R, Mishima M, Mishima M, Mohamed RM, Mévélec MN, Mévélec MN, Nicola Gargano, Nielsen HV, Nielsen HV, Petersen E, Petrovsky N, Pettersen EK, Pfefferkorn ER, Qu D, Reikvam A, Roque-Resendiz JL, Sabin AB, Sayles PC, Schaap D, Scorza T, Siachoque H, Sibley LD, Silveira C, Stanley AC, Stockinger B, Supply P, Taneja V, Vandepapelierea P, Velge-Roussel F, Velge-Roussel F, Vercammen M, Vogel N, Vyas JM, Waldeland H, Wang H, Wilkins MF, Williams MA, Xue M, Xue M, Yang CD, Yarovinsky F, Zenner L, Zhang G, Zhang J, Zimmermann S   +117 more
core   +3 more sources

Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients sera [PDF]

, 2008
Background American Trypanosomiasis or Chagas disease is caused by Trypanosoma cruzi which currently infects approximately 16 million people in the Americas causing high morbidity and mortality.
de Moraes, Milene H., Egera, Iriane, Girardia, Fabiana P., Grisard, Edmundo C., Guarneria, Alessandra A., Rodriguesa, Juliana B., Steindel, Mario, Tyler, Kevin M.   +7 more
core   +3 more sources

Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii [PDF]

, 2014
Toxoplasma gondii is an obligate intracellular parasitic protozoan that has a wide host range and causes a zoonotic parasitosis called toxoplasmosis. This infection causes significant morbidity, costs for care and loss of productivity and suffering.
Hong Yin, Yanhua Wang
core   +1 more source

A mouse protozoan boosts antigen-specific mucosal IgA responses in a specific lipid metabolism- and signaling-dependent manner

Nature Communications
IgA antibodies play an important role in mucosal immunity. However, there is still no effective way to consistently boost mucosal IgA responses, and the factors influencing these responses are not fully understood. We observed that colonization with the murine intestinal symbiotic protozoan Tritrichomonas musculis (T.mu) boosted antigen-specific ...
Yanbo Kou, Shenghan Zhang, Junru Chen, Yusi Shen, Zhiwei Zhang, Haohan Huang, Yulu Ma, Yaoyao Xiang, Longxiang Liao, Junyang Zhou, Wanpeng Cheng, Yuan Zhou, Huan Yang, Zhuanzhuan Liu, Yanxia Wei, Hui Wang, Yugang Wang   +16 more
openaire   +3 more sources

Evaluation of parasite antigens in Elisa for the detection of toxoplasma infection in pigs [PDF]

, 2010
One-third of the human world population is infected with the protozoan parasite Toxoplasma gondii Toxoplasmosis is an old disease but is still very underreported and neglected ...
Cox, Eric, De Craeye, S, Melkebeek, Vesna, Verhelst, Delfien   +3 more
core  

A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis [PDF]

Previous studies demonstrated safety, immunogenicity and efficacy of DNA/modified vaccinia virus Ankara (MVA) prime/boost vaccines expressing tryparedoxin peroxidase (TRYP) and Leishmania homologue of the mammalian receptor for activated C kinase (LACK ...
Alcami, Antonio, Antoniou, Maria, Begoña Ruiz-Argüello, Maria, Blackwell, Jenefer M., Carson, Connor, Christodoulou, Vasiliki, Courtenay, Orin, Messaritakis, Ippokratis   +7 more
core   +1 more source

Securing poultry production from the ever-present Eimeria challenge [PDF]

, 2013
Blake, D P, Tomley, F M
core   +1 more source